Fig. 6From: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluationChanges in cellular morphology of PC3 cells; dose and time-dependent response after treatment with nanoformulations of VC-loaded in TCs-HA as compared to pure vincristineBack to article page